TITLE

Mupirocin-Based Decolonization of Staphylococcus aureus Carriers in Residents of 2 Long-Term Care Facilities: A Randomized, Double-Blind, Placebo-Controlled Trial

AUTHOR(S)
Mody, Lona; Kauffman, Carol A.; McNeil, Shelly A.; Galecki, Andrzej T.; Bradley, Suzanne F.
PUB. DATE
December 2003
SOURCE
Clinical Infectious Diseases;12/1/2003, Vol. 37 Issue 11, p1467
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Mupirocin has been used in nursing homes to prevent the spread of methicillin-resistant Staphylococcus aureus (MRSA), despite the lack of controlled trials. In this double-blind, randomized study, the efficacy of intranasal mupirocin ointment versus that of placebo in reducing colonization and preventing infection was assessed among persistent carriers of S. aureus. Twice-daily treatment was given for 2 weeks, with a follow-up period of 6 months. Staphylococcal colonization rates were similar between residents at the Ann Arbor Veterans Affairs (VA) Extended Care Center, Michigan (33%), and residents at a community-based long-term care facility in Ann Arbor (36%), although those at the VA Center carried MRSA more often (58% vs. 35%; P = .017). After treatment, mupirocin had eradicated colonization in 93% of residents, whereas 85% of residents who received placebo remained colonized (P < .001). At day 90 after study entry, 61% of the residents in the mupirocin group remained decolonized. Four patients did not respond to mupirocin therapy; 3 of the 4 had mupirocin-resistant S. aureus strains. Thirteen (86%) of 14 residents who became recolonized had the same pretherapy strain; no strain recovered during relapse was resistant to mupirocin. A trend toward reduction in infections was seen with mupirocin treatment.
ACCESSION #
11472252

 

Related Articles

  • Decolonization of nostrils and skin of nasal carriers of S. aureus at admission prevented hospital-associated infection. Golan, Yoav // ACP Journal Club;5/18/2010, Vol. 152 Issue 5, p8 

    The article reports on a study related to the identification of nasal carriers of Staphylococcus (S.) aureus and decolonization of nostrils in preventing hospital-associated S. aureus infection. As stated, 918 adults were examined on rapid screening for nasal carriage of S. aureus at hospital...

  • Clippings. Shah, Amit // Indian Pediatrics;Oct2012, Vol. 49 Issue 10, p850 

    This section discusses various studies related to pediatrics. A study published in the "Journal of Periantology" examined the use of long-term prophylactic mupirocin in reducing Staphylococcus aureus colonization and infection. Another study, which appeared in "Archives in Internal Medicine,"...

  • Rigorous cleaning blocks MRSA from prior patient.  // Hospital Infection Control & Prevention;May2009, Vol. 36 Issue 5, p57 

    The article describes research into the disinfection of hospital rooms that was presented at the Society for Healthcare Epidemiology of America (SHEA) annual meeting in San Diego, California. It states that the risk of a patient contracting methicillin-resistant Staphylococcus aureus (MRSA) frmo...

  • Clinical Effectiveness of Mupirocin for Preventing Staphylococcus aureus Infections in Nonsurgical Settings: A Meta-analysis. Nair, Rajeshwari; Perencevich, Eli N.; Blevins, Amy E.; Goto, Michihiko; Nelson, Richard E.; Schweizer, Marin L. // Clinical Infectious Diseases;3/1/2016, Vol. 62 Issue 5, p618 

    A systematic literature review and meta-analysis was performed to identify effectiveness of mupirocin decolonization in prevention of Staphylococcus aureus infections, among nonsurgical settings. Of the 15 662 unique studies identified up to August 2015, 13 randomized controlled trials, 22...

  • 2. Fusidic acid in skin and soft-tissue infections. Long, Barry H. // Acta Dermato-Venereologica;2008 Supplement, p14 

    Topical antibacterial therapy is an important component in managing skin and soft-tissue infections (SSTIs). Fusidic acid, a narrow-spectrum antibiotic active against Staphylococcus aureus, has shown good skin permeability and low allergenic potential. The resistance rate in S. aureus remains...

  • I must not cheat. Wilson, Clare // New Scientist;10/1/2011, Vol. 211 Issue 2832, p43 

    The article discusses research which would stop bacteria such as Pseudomonas, which can cause pneumonia, from harming people. Some strains of Pseudomonas, called cheater strains, do not attack their hosts, and scientists such as Christian van Delden, Angus Buckling, and Steve Diggle believe that...

  • Staph A detection improved.  // Emerging Food R&D Report;Jan2010, Vol. 20 Issue 10, p6 

    The article reports on the test developed by the United States Dept. of Agriculture- Agricultural Research Service (USDA-ARS) to identify the presence of staphylococcus in foods. The trial has been named as staphylococcal enterotoxin A (SEA) which serves as a tool for food companies to assure...

  • Research: THOMPSON and COLLEAGUES.  // Positive Health;Nov2009, Issue 164, p1 

    The article discusses the Phase II/III randomized controlled clinical trial conducted by G. Thompson and colleagues which assessed the effect of 5% Tea Tree oil (TTO) in preventing multidrug-resistant staphylococcus aureus (MRSA) colonization compared with conventional body wash. It also...

  • Extra cleaner on wards reduces MRSA infections.  // Nursing Standard;8/26/2009, Vol. 23 Issue 51, p17 

    The article discusses a report titled "Measuring the Effect of Enhanced Cleaning in a UK Hospital: A Prospective Cross-Over Study," by researcher S. J. Dancer and colleagues in a 2009 issue of "BMC Medicine." The focus of the study was whether extra cleaning reduced meticillin-resistant...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics